Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ter Heine

Showing results (71-80 of 160) with videos related to

Pageof 16
Sort By:
Therapeutic Advances in Musculoskeletal Disease|December 19, 2022
Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study)Céleste J T van der Togt, Lise M Verhoef, Bart J F van den Bemt, et al.
Rapid Communications in Mass Spectrometry : RCM|July 5, 2007
Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometryRob ter Heine, Carolien G Alderden-Los, Hilde Rosing, et al.
Clinical Pharmacokinetics|February 5, 2025
Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug OlaparibJoanneke K Overbeek, Nielka P van Erp, David M Burger, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patientsEveline Wallenburg, Roger J M Brüggemann, Jason A Roberts, et al.
Clinical and Translational Science|April 1, 2023
Evidence-based rationale for low dose nivolumab in critically ill patients with sepsis-induced immunosuppressionDemy A C van den Haak, Leila-Sophie Otten, Hans J P M Koenen, et al.
Clinical Pharmacokinetics|April 4, 2022
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill PatientsEveline Wallenburg, Rob Ter Heine, Jeroen A Schouten, et al.
International Journal of Cancer|January 19, 2026
No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjectsEsther M Hollander, Alessandra I G Buma, Jenneke Leentjens, et al.
Drugs|December 11, 2021
Optimized Dosing: The Next Step in Precision Medicine in Non-Small-Cell Lung CancerRené J Boosman, Jacobus A Burgers, Egbert F Smit, et al.
European Journal of Clinical Pharmacology|July 29, 2018
Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newbornsRobert B Flint, Rob Ter Heine, Edwin Spaans, et al.
The Journal of Antimicrobial Chemotherapy|October 21, 2023
Pharmacokinetic investigations of isavuconazole in paediatric cancer patients show reduced exposure of isavuconazole after opening capsules for administration via a nasogastric tubeDidi Bury, Tom F W Wolfs, Rob Ter Heine, et al.
Pageof 16

Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
Therapeutic Advances in Musculoskeletal Disease|December 19, 2022
Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study)Céleste J T van der Togt, Lise M Verhoef, Bart J F van den Bemt, et al.
Rapid Communications in Mass Spectrometry : RCM|July 5, 2007
Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometryRob ter Heine, Carolien G Alderden-Los, Hilde Rosing, et al.
Clinical Pharmacokinetics|February 5, 2025
Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug OlaparibJoanneke K Overbeek, Nielka P van Erp, David M Burger, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patientsEveline Wallenburg, Roger J M Brüggemann, Jason A Roberts, et al.
Clinical and Translational Science|April 1, 2023
Evidence-based rationale for low dose nivolumab in critically ill patients with sepsis-induced immunosuppressionDemy A C van den Haak, Leila-Sophie Otten, Hans J P M Koenen, et al.
Clinical Pharmacokinetics|April 4, 2022
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill PatientsEveline Wallenburg, Rob Ter Heine, Jeroen A Schouten, et al.
International Journal of Cancer|January 19, 2026
No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjectsEsther M Hollander, Alessandra I G Buma, Jenneke Leentjens, et al.
Drugs|December 11, 2021
Optimized Dosing: The Next Step in Precision Medicine in Non-Small-Cell Lung CancerRené J Boosman, Jacobus A Burgers, Egbert F Smit, et al.
European Journal of Clinical Pharmacology|July 29, 2018
Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newbornsRobert B Flint, Rob Ter Heine, Edwin Spaans, et al.
The Journal of Antimicrobial Chemotherapy|October 21, 2023
Pharmacokinetic investigations of isavuconazole in paediatric cancer patients show reduced exposure of isavuconazole after opening capsules for administration via a nasogastric tubeDidi Bury, Tom F W Wolfs, Rob Ter Heine, et al.
Pageof 16